Elvium Life Sciences Limited Partnership
Registration:
1
of
2
(2023-11-21
to
2024-09-24)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Elvium Life Sciences will be meeting with public officials with the government British Columbia regarding the decision to list company’s products with the goal of reimbursement of its medications by Pharmacare.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health, Mental Health and Addictions, Science and Technology
|